SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is currently experiencing significant market attention driven by high-profile institutional accumulation, including major positions from Millennium Management and Janus Henderson, despite recent volatility stemming from a bizarre executive controversy. Investors remain focused on the potential of NXC-201 as a disruptive one-and-done BCMA CAR-T therapy, with the community actively debating the company's BLA timeline, upcoming clinical data, and the possibility of a strategic buyout.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

The Shiba Inu community remains highly polarized as supporters highlight the token's evolving ecosystem and burning mechanisms, while detractors dismiss it as an aging project in a potential death spiral. Investors are actively debating the viability of long-term holding versus the risks of holding meme-centric assets in the current market.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is currently trending as investors scrutinize its growth trajectory, balancing impressive global expansion in Robotaxi and ADAS partnerships against concerns over product revenue scaling and profitability. The community is actively debating the company's valuation, questioning management's communication strategy while weighing the potential impact of ongoing share repurchases and upcoming Q1 financial results.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is facing intense volatility as investors debate whether the company is a strategic AI infrastructure player or a limited service provider tethered solely to Dell. Community sentiment is deeply divided, with some investors aggressively accumulating on the dip in anticipation of future facility capacity expansion, while critics point to stagnant revenue growth and ongoing insider selling as major red flags.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

ProShares Ultra Bloomberg Crude Oil is seeing heightened attention as traders react to conflicting reports regarding a potential US-Iran ceasefire and the status of the Strait of Hormuz. While some investors are betting on a supply relief rally, others remain skeptical about the durability of these diplomatic headlines, leading to intense volatility and fierce debate regarding the long-term impact on global energy pricing.

Horizon Quantum Holdings Ltd. engages in the development of software tools. The company is headquartered in Singapore.

Horizon Quantum Holdings Ltd. - Ordinary Shares - Class A

Horizon Quantum is experiencing extreme volatility and intense retail interest following reports that institutional heavyweights and major industry players hold significant stakes, fueling speculation about the company's long-term competitive position. While some community members are betting on a massive squeeze due to a low public float and restricted shares, others are raising red flags regarding the company's early-stage technology and lack of commercial revenue compared to established quantum competitors.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO) is facing significant price volatility driven by community concerns regarding the departure of a major subnet developer and broader debates about the project's level of decentralization. Despite these headwinds, many investors view the current dip as a strategic accumulation opportunity, maintaining long-term conviction in the network's AI infrastructure potential and staking yields.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is attracting intense community interest driven by its pivotal role in the AI infrastructure buildout and a massive, growing order backlog that highlights the critical need for power grid and data center equipment. While some investors are concerned about secondary offerings and insider activity, many are viewing recent pullbacks as buying opportunities, citing the company's strong revenue growth and indispensable position in the electrical supply chain as key long-term catalysts.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

ChainLink is seeing heightened activity as community members debate its long-term potential against a backdrop of technical trendline breakdowns and broader market volatility. Investors are actively discussing the project's institutional role in the evolving digital asset economy and its integration within key financial infrastructure as a catalyst for future sentiment.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is drawing significant community interest as investors increasingly prioritize monthly cash flow strategies that pair Nasdaq-100 exposure with high-yield income potential. Conversations are currently centered on the fund's competitive distribution consistency, its total return profile compared to other derivative-income peers, and its role as a core holding for long-term passive income builders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EXEL vs. ILMN: Which Stock Is the Better Value Option?

Exelixis to Release Second Quarter 2026 Financial Results on Wednesday, August 5, 2026

Exelixis, Inc. (Nasdaq: EXEL) announced today that its second quarter 2026 financial results will be released on Wednesday, August 5, 2026 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss the results and provide a...

Alkermes (ALKS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Alkermes (ALKS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Exelixis (EXEL) Earnings Expected to Grow: Should You Buy?

Exelixis (EXEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?

Exelixis (EXEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised

JNJ tops Q2 earnings and sales estimates, driven by key drug growth, and raises its 2026 outlook despite a slight MedTech sales miss.

Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN

Biotech is gaining momentum as healthcare leads higher, with several drugmakers and life sciences companies showing improving earnings trends and breakouts.

EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth?

Exelixis' zanzalintinib faces a setback, but an FDA review, phase III trials and Cabometyx momentum keep investors focused on its growth path.

Stocks Look Shaky, But This Sector is Booming (Biotech)

Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market leaders.

Here's Why Exelixis (EXEL) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Exelixis Inc

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.85	--	--	N/A
Q1 '26	$0.76	$0.87	13.76%	BEAT
Q4 '25	$0.83	$0.94	13.31%	BEAT
Q3 '25	$0.69	$0.78	13.87%	BEAT
Q2 '25	$0.66	$0.75	14.41%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

EXELExelixis Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest EXEL News